?Therapeutic combivent spiriva cat. ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. combivent spiriva is marketed.

to: navigation, searchIpratropium/salbutamolCombination ofIpratropium combivent spiriva antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number ?ATC combivent spiriva ?PubChem ?Therapeutic combivent spiriva cat. ?Legal statusRoutes InhalationThe combination combivent spiriva ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v • d • eDrugs for obstructive airway diseases: combivent spiriva (R03)Adrenergics, inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • Fenoterol • TerbutalineLong acting ?2-agonists (LABA): Bambuterol • Clenbuterol • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone • combivent spiriva Ipratropium •.

• Fenoterol • TerbutalineLong acting ?2-agonists (LABA): Bambuterol • Clenbuterol • Formoterol Clenbuterol.